The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review
Open accessThe DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Abstract
Comorbid psychiatric disorders in adults with ADHD are important because these comorbidities might complicate the diagnosis of ADHD and also worsen the prognosis. However, the prevalence of comorbid psychiatric disorders in adult ADHD varies according to the diagnostic tools used and the characteristics of target populations. The purpose of this review was to describe the prevalence of comorbid psychiatric disorders in adults with ADHD compared with adults without ADHD. Thirty-two studies published before August 2022 were identified and classified according to diagnosis of other psychiatric disorder in those with ADHD. The most frequent comorbid psychiatric disorder in the ADHD group was substance use disorder (SUD), followed by mood disorders, anxiety disorders, and personality disorders. The prevalence of these four disorders was higher in the ADHD group, whether or not subjects were diagnosed with other psychiatric disorders. In addition, the diversity of ADHD diagnostic tools was observed. This also might have affected the variability in prevalence of comorbidities. Standardization of ADHD diagnostic tools is necessary in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epidemiological studies consistently show high psychiatric comorbidity, with 50–80% of adults meeting criteria for at least one additional mental disorder [106,107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [107]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Substance use disorders (SUD) are markedly over-represented, with a twofold increased risk of alcohol or drug dependence and earlier onset of use [14,107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [107]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent executive and organizational deficits after mood stabilization strongly suggest co-existing ADHD [107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [107]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depressive and anxiety symptoms are typically episodic, often fluctuating with life stressors, whereas attentional deficits in ADHD are chronic, pervasive, and present across developmental stages [106,107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [107]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Comorbidity predicts more severe impairment and reduced response to medication, and is especially prominent in forensic populations [107].”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [107]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874 · cited 3×
“Study search and data sources The methodology of the present review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) [17].”
MethodInfluentialThe worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346 · cited 1×
“5% [4], which is moderate compared to its prevalence in children, which is about 5% [5].”
BackgroundKessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
KESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 7×
“Five studies used the ASRS alone to evaluate ADHD in adults, and the rest of the studies used more than one tool to evaluate ADHD.”
MethodInfluentialPrevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627 · cited 1×
“Considering that the worldwide prevalence rate of bipolar disorder is estimated as 1–3% [75, 76], which was similar to that of the non-ADHD general population in our study, the prevalence of bipolar disorder in the ADHD group was greater than 3% in all 10 studies.”
ResultMerikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399 · cited 1×
“Considering that the worldwide prevalence rate of bipolar disorder is estimated as 1–3% [75, 76], which was similar to that of the non-ADHD general population in our study, the prevalence of bipolar disorder in the ADHD group was greater than 3% in all 10 studies.”
ResultFARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267 · cited 1×
“According to a previous meta-analysis, 65% of children who were diagnosed with ADHD have persistent ADHD symptoms in adulthood [3].”
MethodPrevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601 · cited 1×
“5% [4], which is moderate compared to its prevalence in children, which is about 5% [5].”
BackgroundBiederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498 · cited 1×
“This might because the interest in adult ADHD had increased based on the results of longitudinal follow-up studies on children and adolescents with ADHD [54, 55].”
Background
Research works printed but not linked: 2
- Adler L, Kessler RC, Spencer T. Adult ADHD self-report scale-v1. 1 (ASRS-v1. 1) symptom checklist. New York, NY: World Health Organization. 2003.
- Epstein J, Johnson DE, Conners CK. Conners’ Adult ADHD Diagnostic Interview for DSM-IV™. 2001.
Cited by
Items 101–200 of 221
Damtie, Y., Betts, K. S., Dachew, B. A., Ayano, G., & Alati, R. (2025) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2025.112167 · Cited by 2
Mark, E. G., Molina, B. S. G., Wilson, M. A., Zeanah, C. H., & Joseph, H. M. (2025) · JCPP Advances · doi:10.1002/jcv2.70029 · Cited by 3
Dezfouli, R. A., Hashemzadeh, S., & Mohammadzadeh, A. S. (2025) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-025-00993-2 · Cited by 4
“Research indicates that ADHD can continue into adulthood, contributing to numerous difficulties such as co-occurring psychiatric conditions, emotional distress, academic struggles, reduced productivity, social challenges, disability, and increased morbidity [5–7].”
Meral, Y., Gökler, M. E., Albayrak, Z. S., Keleş, H. K., Serdengeçti, N., Yazıcı, M. S., & Tarakçıoğlu, M. C. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251349245 · Cited by 1
“Anxiety disorders are highly prevalent in ADHD (Choi et al., 2022), and separation anxiety is typically considered a diagnosis more common in preadolescence (Rapee et al., 2023).”
Çankaya, P. K. (2025) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1719949 · Cited by 1
Ryan, J. E., Herens, A., Fruchtman, M., Veliz, P. T., Kelly, E. L., & Worster, B. K. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251364575 · Cited by 2
“Finally, comorbid psychopathologies are common in adults diagnosed with ADHD and include mood and anxiety disorders, substance use disorders, and personality disorders (Choi et al., 2022; Katzman et al., 2017).”
Adult ADHD and Its Familial Associations: Neuropsychological Profiles and Psychiatric Comorbidities
Makkar, T. K., Arun, P., Gupta, N., & Mittal, H. (2025) · Journal of Indian Association for Child and Adolescent Mental Health · doi:10.1177/09731342251375193 · Cited by 2
Kariv, D., Mejia, J. H., Cisneros, L., Kashy‐Rosenbaum, G., & Guiliani, F. (2025) · Small Business Economics · doi:10.1007/s11187-025-01112-4 · Cited by 1
“These entrepreneurs’ low self-esteem and confidence (Cook et al., 2014; Kita & Inoue, 2017) can adversely impact their mental health perceptions (Choi et al., 2022; Oerbeck et al., 2019; Vörös & Lukovszki, 2021) and, consequently, their growth aspirations (e.g., Hatak et al., 2021; Lerner et al.,…”
InfluentialViloxazine Extended-Release: A Review in Attention-Deficit/Hyperactivity Disorder in Adults
Syed, Y. Y. (2025) · CNS Drugs · doi:10.1007/s40263-025-01227-y · Cited by 4
“Mood and anxiety disorders are common in patients with ADHD [49].”
Socratous, G., Haussler, S. M., Finning, K., Howard, D. M., Hayes, R. D., Downs, J. M., & Wickersham, A. (2025) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2025.103091 · Cited by 3
Hayasaka, T., Nagashima, I., Hoshino, M., Teruya, K., Matumoto, Y., Murao, M., Maruki, T., Watanabe, M., Katagiri, T., Imamura, Y., et al. (2025) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70254 · Cited by 1
“7,8 14 When assessing comorbidity in patients with suspected ADHD, the Adult ADHD Self ‐ Report Scale (ASRS) and the ADHD Rating Scale are commonly used.”
Celestino, M. J., Bezerra, M. P., Mariani, M., Depoli, M. A. R., Monteiro, A. B. A., Lima, C. D. S., Alves, L. G., & Ribeiro, E. L. (2026) · Revista Contemporânea · doi:10.56083/rcv6n1-072 · Cited by 2
Antipsychotic treatment in children and adults with ADHD: a systematic review of efficacy and safety
Sarli, G., Maddalena, S., Polidori, L., & Magistri, C. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01140-1 · Cited by 1
Alarachi, A., McNeely, H. E., Rowa, K., & McCabe, R. E. (2026) · British Journal of Clinical Psychology · doi:10.1111/bjc.70048 · Cited by 3
“Moreover, most participants had additional mental health diagnoses as is highly common in those with ADHD or ARDs (Choi et al., 2022; Davies et al., 2023; Essau et al., 2018; Fayyad et al., 2017; Ruscio et al., 2017), supporting the ecological validity and generalizability of the findings.”
Kranz, T. M., McNeill, R. V., Jacob, C. P., Ahrens, K. F., Neumann, R. J., Plichta, M. M., Kollmann, B., Streit, F., Tüscher, O., Lieb, K., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04008-3 · Cited by 1
“Lifetime prevalence rates for MDD are signi fi cantly higher in aADHD patients than in the general population [5, 6].”
Adamou, M., Fullen, T., Crisp, R., Hallett, E., Spencer, L., Wharton, L., & Jones, S. L. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1789686 · Cited by 1
A comprehensive overview of the biological foundations of ADHD
Folego-Temoteo, I., Lima, Y. C., Grevet, E. H., Vidor, M. V., Tavares, M. E., da Silva, B. S., Bau, C. H. D., & Rovaris, D. L. (2026) · Bioscience Reports · doi:10.1042/bsr20254061 · Cited by 1
“In parallel, the comorbidity profile shifts, with substance use, mood, anxiety, and personality disorders more frequently reported among adults with ADHD [51].”
Padaigaitė, E., Hammerton, G., Heron, J. E., Eyre, O., Michelini, G., Wilson-Newman, A., Garavini, C., Eley, T. C., Thapar, A., & Riglin, L. (2026) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2026.06.001 · Cited by 1
Hoare, E., Harrison, M., Timperley, S., Riordan, J., Rowlings, J., Hedley, D., Brown, C. M., Bennett, B., John, T., Upward, K., et al. (2026) · Neurodiversity · doi:10.1177/27546330261464728 · Cited by 1
Costa, Í. M., Melo, C. D. F., Gontijo, D. F., Dourado, S., Tavares, L. L. P., & Bezerra, C. M. (2026) · Journal of Attention Disorders · doi:10.1177/10870547261469218 · Cited by 2
The Role of Age in Adult ADHD Quality Care: A Longitudinal Analysis of Electronic Health Record Data
Callen, E. F., Clay, T. L., Alai, J., Goodman, D. W., Adler, L. A., & Faraone, S. V. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231218042 · Cited by 3
“While prior studies have indicated that all adults with ADHD should be screened for other psychiatric disorders (Anker et al., 2017; Barkley & Brown, 2008; Choi et al., 2022; Holst & Thorell, 2017, 2020; Sobanski, 2006), we found that younger adults were screened at a higher rate than older adults.”
BackgroundA IMPORTÂNCIA DO DIAGNÓSTICO DE TDAH EM ADULTOS
Macedo, L. R., & Rocha, P. A. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n8-152 · Cited by 4
Levine, S. Z., Rotstein, A., Reichenberg, A., & Wallace, R. B. (2025) · Psychological Medicine · doi:10.1017/s0033291725101347 · Cited by 1
“This interpretation aligns with prior research documenting the frequent co-occurrence of depression and ADHD, particularly in adults through middle age (Choi et al., 2022).”
Chen, E., & Danzak, R. L. (2025) · Perspectives of the ASHA Special Interest Groups · doi:10.1044/2025_persp-24-00303 · Cited by 1
Neuropsychiatric and Social Consequences of Attention Deficit Hyperactivity Disorder in FemalesPreprint
Kelly, C. A., Kelly, C., Taylor, R., & Gullon-Scott, F. (2023) · Qeios · doi:10.32388/6odysg.7
Neuropsychiatric and Social Consequences of Attention Deficit Hyperactivity Disorder in FemalesPreprint
Kelly, C. A., Kelly, C., Taylor, R., & Gullon-Scott, F. (2023) · Qeios · doi:10.32388/6odysg.8
Martsenkovsky, I., Martsenkovska, I. I., & Makarenko, H. V. (2024) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.20.2.2024.1052
Adhd Symptoms are Common and Associated with Worse Glycemic Control in Adults with Type 1 DiabetesPreprint
Zhang‐James, Y., Draytsel, D. Y., Carguello, B., Faraone, S. V., & Weinstock, R. S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4856029
Decoding complexity: a data-driven approach to unraveling transdiagnostic markers in psychiatry
Meijs, H. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240618hm · Cited by 1
Udal, A. H., Stray, L. L., Pripp, A. H., Stray, T., & Egeland, J. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241273102
“Besides, ADHD is often comorbid with other psychiatric disorders, above all affective, anxiety, personality-and substance use disorders (Choi et al., 2022), which may be the presenting problems by referral to specialist health services (Pehlivanidis et al., 2014).”
BackgroundMalik, S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006539 · Cited by 1
Calitatea vieţii la adulţii cu ADHD şi abuz de substanţe psihoactive
Buică, A. M., Gheorghe, C., Cucu, M., Mihăilescu, I., Andrei, E., Stancu, M., & Rad, F. (2024) · Psihiatru ro · doi:10.26416/psih.79.4.2024.10269
Scarabelli, I., de Freitas, B. L., das Neves, V. J., & de Oliveira, L. M. (2024) · Revista Contemporânea · doi:10.56083/rcv4n12-208
Normative Data for Objective ADHD Smartphone Application in a General Population
Gustafsson, U., Nolen, R., Casals, N., Larsson, S., Sanyal, R. Y., & Hansen, M. (2025) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/0117450179377329250131072308 · Cited by 1
Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants: Reducing Harms
Arceneaux, L., Alrimawi, I., & Kverno, K. S. (2025) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20250212-02 · Cited by 3
Substance use disorder in adolescents with attention deficit hyperactivity disorder
Arafa, O. E., Eldeeb, F. A., Hodeib, H., & Seleem, M. A.-H. (2025) · Tanta Medical Journal · doi:10.4103/tmj.tmj_97_24
Ribeiro, M. I., & França, G. (2025) · Acta Médica Portuguesa · doi:10.20344/amp.21937 · Cited by 2
ADHD and problematic substance use
Hjerrild, S., Wissing, S., & Holm, T. (2025) · Ugeskrift for Læger · doi:10.61409/v01250005
Reiner, A., Greenberg, A. J., Jarrett, M. A., Becker, S. P., Kofler, M. J., Luebbe, A. M., Burns, G. L., & Garner, A. A. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251340039
“More specifically, ADHD often co-occurs with internalizing disorders such as anxiety disorders and depression (Choi et al., 2022).”
Barbaresi, W. J., Bannett, Y., Blum, N. J., Chong, S. C., Clark, J., Dall, M., Epstein, J. N., Fellinger, J., Froehlich, T. E., Hofer, J., et al. (2025) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001376
Soignants libéraux et TDAH : enjeux et défis
Menard, O., & Roulin, M. (2025) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2024.11.002
Anderson-Fletcher, E. A., Woller, S. J., Lebeaut, A., & Vujanovic, A. A. (2025) · Journal of Workplace Behavioral Health · doi:10.1080/15555240.2025.2509120
“…and ADHD symptom severity (Bodalski et al., 2019; Christiansen et al., 2019; Hirsch et al., 2018; Soler-Guti � errez et al., 2023) as well as ADHD symptom severity and comorbid mental health outcomes (i.e., depression, anxiety, PTSD; Choi et al., 2022; D’Agati et al., 2019; Katzman et al., 2017).”
InfluentialBrunault, P., El‐Hage, W., Cortese, S., Bachellier, J., Luca, A. D., Archi, S. E., Scocard, A., Belayachi, S., Barrault, S., & Ballon, N. (2026) · International Journal of Mental Health · doi:10.1080/00207411.2026.2705599
Bertaccini, R., & Capuozzo, A. (2025) · QUADERNI DI PSICOTERAPIA COGNITIVA · doi:10.3280/qpc55-2024oa20372
(2025) · Wiley eBooks · doi:10.1002/9781118941430.refs
Connolly, R. D., Lamont, A., & Speed, D. (2025) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2025.100165
Muchos adultos sufren TDAH sin saberlo: cómo detectarlo y hacerle frente
Arrondo, G. (2024) · The Conversation · doi:10.64628/aao.g377nrhg5
Alacha, H. F., & Bufferd, S. J. (2025) · Journal of Emotional and Behavioral Disorders · doi:10.1177/10634266251363946
“Anxiety affects approximately 40% of youth with ADHD in the general population, increasing to 57% in clinical settings, with higher prevalence among girls and far surpassing the 2% to 15% rate of anxiety found in the general pediatric population (Choi et al., 2022; Danielson et al., 2024).”
Comprehensive Attention Test as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder
Yoo, Y., Lee, J., Kim, B., & Yoo, H. K. (2025) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.250034
“Differentiating attention impairments due to ADHD from those due to other causes, such as depressive mood and anxiety, is often an important yet confounding issue that complicates the diagnosis [9].”
Wu, Y., Chua, K., McManus, S., Morgan, Z. L., & Oram, S. (2025) · medRxiv · doi:10.1101/2025.10.08.25337602
“…higher rates of comorbid mental disorders, including substance use disorders, depressive disorders, bipolar disorders, and personality disorders, (Choi et al., 2022; Mak et al., 2020; Mak et al., 2022), all of which have been associated with an increased risk of IPV perpetration (Abramsky et…”
Uncovering Adult Attention-deficit/ Hyperactivity Disorder (ADHD): A Hidden Yet Treatable Condition
Shah, R., & Sultan, M. A. (2025) · Journal of Indian Association for Child and Adolescent Mental Health · doi:10.1177/09731342251383611
“A recent meta-analysis 14 including world-wide studies revealed that the most frequent comorbidities are SUD, followed by mood disorders, anxiety disorders, and personality disorders.”
Spike, E., Srasuebkul, P., Kariminia, A., Butler, T. G., & Trollor, J. N. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-102805
Animal models of attention-deficit/hyperactivity disorder: Diversity and validity
Nehme, S. B. S., Sánchez‐Sarasúa, S., Medrano, M., Bouchatta, O., Bitar, T., Alameddine, A., Galineau, L., Brunault, P., Kerekes, N., Sánchez‐Pérez, A. M., et al. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100108
Lai, Q.-J., Zhang, S.-Y., Zhang, X.-Y. N., Liu, N. Y., Wang, W.-C. N., Li, H. M., Wang, Y.-F., Liu, L., & Qian, Q. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap49137
“The estimated prevalence of MDD in the ADHD group ranges from 8.6% to 55% in the general population and 15.4% to 39.7% in the clinical population [5].”
InfluentialKauppinen, I., Miettunen, J., Nordström, T., Halt, A., & Hurtig, T. M. (2026) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-025-03027-7
Rosario-Hernández, E., Rovira-Millán, L. V., & Blanco-Rovira, R. A. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1702403
Heltne, A., Kenter, R. M. F., Gulseth, R., & Nordgreen, T. (2026) · Internet Interventions · doi:10.1016/j.invent.2026.100922
“This is encouraging given that depression, anxiety and personality pathology are among the most common comorbid conditions to ADHD (Choi et al., 2022).”
Abudasser, A. M., Abudasser, O. A. M., Almazni, A. S., Alhasaniah, A. R., & Javali, M. A. (2026) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1860_25
“4-8] Among these, oral health problems are particularly significant yet frequently underestimated from many healthcare professionals.”
Wudy, S., Mauche, N., Huang, J., Makiol, C., & Strauß, M. (2026) · Research Square · doi:10.21203/rs.3.rs-8518298/v1
Cardiovascular Medicine Use Among Adults With ADHD: A Nationwide Study in Australia
Araki, M., Zoëga, H., Gillies, M. B., Falster, M. O., Peiris, D., Pearson, S., Larsson, H., & Costa, J. D. O. (2026) · Journal of Attention Disorders · doi:10.1177/10870547261418763
“Substance use, poor mental health, and productive events could serve as cardiovascular risks (Agnew-Blais et al., 2018; Choi et al., 2022; Young et al., 2020).”
Cabelguen, C., Challet‐Bouju, G., Thiabaud, E., Donnio, Y., Lefebvre, L., Hardouin, J.-B., & Grall‐Bronnec, M. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111698
Williams, E.-D. G., Vakil, F., Abubakare, O., Latin, A., Ware, L., Nelson, D., & Smith, M. J. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1766641
Suetani, S., Honarparvar, F., Muller, P., Kesby, J. P., & Parker, S. (2026) · Australasian Psychiatry · doi:10.1177/10398562261439662
Kettman, A., & Murakami, M. M. (2026) · Cureus · doi:10.7759/cureus.106581
“Although traditionally considered a childhood-onset disorder, ADHD frequently continues into adolescence and adulthood, often accompanied by comorbid psychiatric disorders such as anxiety, mood, and substance abuse disorders [2].”
Adolescence and ADHD: Practical proposals regarding the transition of care
Cabelguen, C., Aoul, S. H., Kammerer, E., Brustolin, D., Shadili, G., Vesproumis, P., Romo, L., & Purper‐Ouakil, D. (2026) · L Encéphale · doi:10.1016/j.encep.2026.01.007 · Cited by 1
Zipursky, J. S., Vigod, S. N., Babujee, A., Barker, L. C., Bolea-Alamanac, B. M., Clark, C. T., Cohen, E., Dennis, C., Gomes, T., Lu, H., et al. (2026) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2026.101969
Zurchimitten, G., Oliveira, B. R. F., Kremer, R., & Izídio, G. S. (2026) · Developmental Psychobiology · doi:10.1002/dev.70155
Glăvan, D., Udriștoiu, I., Hermann, D. M., Fîlfan, M., Doeppner, T. R., Gheorman, V., & Popa‐Wagner, A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111700
Zappullo, I., Cecere, R., Scuotto, A., Lauro, A., Senese, V. P., Trojano, L., & Conson, M. (2026) · Mindfulness · doi:10.1007/s12671-026-02831-9 · Cited by 1
“their lifespan (Angold et al., 1999; Choi et al., 2022; De Rossi et al., 2023).”
Lynch, J. D., Subedi, S., Zimon, M., Peisch, V. D., & Arnett, A. B. (2026) · Journal of Attention Disorders · doi:10.1177/10870547261438181
“Further, the elevated rates of psychiatric comorbidity among youth with ADHD persist into adult-hood (Choi et al., 2022).”
Halms, T., Grimmer, J., Hindermayr, S., Leucht, S., Sonntag, N., Gensichen, J., Kumar, M., Xue, S., Luykx, J. J., & Hasan, A. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117190
Zhang, L.-Q., Pan, M., Dong, M., Xin, K., Yu, Z.-Y., Zhang, S.-Y., Li, H.-M., Liu, L., Wang, Y.-F., & Qian, Q. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08130-w
“Substance use, mood, anxiety, and personality disorders are among the most commonly reported comorbidities, and their prevalence is consistently higher than that observed in non-ADHD populations [7].”
Parr, J. J., King, M. R., & Franks, C. (2026) · Clinical and Translational Neuroscience · doi:10.3390/ctn10020012 · Cited by 1
Sugawara, N., Tabuchi, T., Tokumitsu, K., & Yasui‐Furukori, N. (2026) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70137
Devenish, B. D., Weiner, L., & Papadopoulos, N. V. (2026) · Australian Journal of Psychology · doi:10.1080/00049530.2026.2679669
“Increased comorbidity with mental health disorders has been observed in adults with ADHD (Choi et al., 2022), which results in greater functional severity and impairment, and increased suicidality, than when these conditions present alone (DiLorenzo et al., 2021).”
The Prevalence of Self-reported ADHD among University Students in JordanPreprint
Al‐omoush, O., Farah, S. M., Ihsan, M., Al-Safadi, R., Aldaoud, Y., Alali, L., Ahmed, L. M., Al-Hijazin, A., Shahatit, S., Al-Shenag, H., et al. (2026) · medRxiv · doi:10.64898/2026.05.29.26354419
Callaly, T., Elshazly, H., Lundin, R. M., Mulraney, M., Whyte, M., & Hall, S. (2026) · Australasian Psychiatry · doi:10.1177/10398562261455841
Koyuncu, Z., Evcil, F. Y., Kilimci, Ö. S., Kuzu, S., Poyraz, C. A., Demirel, Ö. F., & Tarakçıoğlu, M. C. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08299-0
“…review, among adults with ADHD, the prevalence of any depressive disorder was reported at 8.6% to 55%, and the prevalence rates of anxiety disorders were reported at 4.3% to 47.1% [8]; these wide ranges likely reflect differences in samples, diagnostic methods, and measurement approaches.”
InfluentialTurchmanovych-Hienkel, N., Dykins, M. M., Abalos, S. A., Shapiro, G., Wang, Y., Finley, J. A., Robinson, A. D., Cerny, B. M., Phillips, M. S., Ulrich, D. M., et al. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.06.029
Chen, T., Tawfig, A.-M., Fahmy, L., Overton, P. G., & Dommett, E. J. (2026) · Neurodiversity · doi:10.1177/27546330261462255
Who benefits from ADHD in entrepreneurship? Intelligence and gender as critical boundary conditions
Tran, M. H., Yu, W., Wiklund, J., & Stephan, U. (2026) · Applied Psychology · doi:10.1111/apps.70113 · Cited by 1
Hoskins, J. I., Gooch, D., & Gilligan-Lee, K. (2026) · Journal of Attention Disorders · doi:10.1177/10870547261459712
“Choi et al. (2022) concluded that prevalence rates of these conditions are higher in samples with ADHD compared to samples without ADHD, irrespective of the presence of any other prior mental health diagnoses.”
InfluentialEva, I. S., Mim, N. A., Saikat, E. H., & Hossain, M. J. (2026) · Research Square · doi:10.21203/rs.3.rs-10243973/v1
Mastrantonio, F., Kovshoff, H., & Armstrong, H. L. (2026) · International Journal of Transgender Health · doi:10.1080/26895269.2026.2697290
ADHD and Mental Health Comorbidities
Ayano, G., Pollard, C. M., Rooney, R. M., & Alati, R. (2026) · SpringerBriefs in modern perspectives on disability research. · doi:10.1007/978-981-95-8712-4_3
Jannini, T. B., Ciocca, G., Giannini, T., Nagy, L., Koós, M., Kraus, S. W., Potenza, M. N., Demetrovics, Z., & Bőthe, B. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10691
Yao, H., Zhou, M., Brikell, I., D'Onofrio, B. M., Kuja‐Halkola, R., Li, L., Lichtenstein, P., Larsson, H., Pettersson, E., & Chang, Z. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03770-6 · Cited by 1
Pleshkevich, M., Broomfield, R. R., Burton, S., Castro, G., Gill, A. G., Jerram, M. W., & Parsa, S. (2026) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acag057
Baou, C. E., Suh, J. W., Saunders, R., Buckman, J. E. J., Hickmott, N., Corrigan, L., Clements, H., Dagnan, D., Donnellan, W. J., Mandy, W., et al. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101798
“To contextualise the generalisability of study findings, we also calculated the expected prevalence of ADHD in a population of people with depression or anxiety 6 and compared it to the prevalence of ADHD in the cohort.”
Rahali, Y., Dennison, C. A., Thapar, A., & Thapar, A. K. (2026) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-026-03156-7
Kohe, S. E., Gowing, E. K., Seo, S., Grattan, D. R., Kokay, I. C., Zheng, Y., Liu, P., & Oorschot, D. E. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107573
Diagnostic Formulation of ADHD
Doyle, K., & Pfeiffer, K. (2026) · Springer eBooks · doi:10.1007/978-3-032-24171-9_5
Comprehensive Assessment of ADHD Across the Lifespan
Llerena, K., & Melland, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-24171-9_3
ADHD and Mental Health Education for Nurse Practitioners: Strategies to Advance Equity
Waite, R. L., & Kverno, K. S. (2026) · Springer eBooks · doi:10.1007/978-3-032-24171-9_2
O’Leary, A., Potter, A. L., Rose, K., Pavlopoulou, G., & Tibber, M. S. (2026) · Autism in Adulthood · doi:10.1177/25739581261480482
Gomez, R., & Houghton, S. D. (2026) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20260012
“Studies involving adults have shown that individuals with BD [5,6] and ADHD [3,4,11,26] will show high comorbidity with many other psychological disorders, with anxiety disorders being most prominent [5,7,27–29].”
ADHD: Beyond Core Symptoms and Specialist Care
Jaeschke, R. R. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15176570
Attention-deficit hyperactivity disorder and perinatal mental illness: a population-based study
Vigod, S. N., Zipursky, J. S., Babujee, A., Barker, L. C., Bolea-Alamanac, B. M., Clark, C. T., Cohen, E., Dennis, C., Feldman, M., Gomes, T., et al. (2026) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-026-03206-0
Metadata
- Authors
- Choi, W.-S., Woo, Y. S., Wang, S.-M., Lim, H. K., & Bahk, W.-M.
- Affiliations
- Hallym University Sacred Heart Hospital (KR)
- Catholic University of Korea (KR)
- Corresponding author
- Bahk, Won-Myong
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-11-04
- Volume
- 17
- Issue
- 11
- Pages
- e0277175
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC9635752
- OpenAlex
- W4308168686
- Semantic Scholar
- 2c2766998bcc8e2358d99da483257424acec90c5
- Cited by
- 221
- References
- 82
- Citations by year
- 2026: 83 · 2025: 75 · 2024: 42 · 2023: 21
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- adult ADHD, psychiatric comorbidity, prevalence, substance use disorders, mood disorders, anxiety disorders, personality disorders
- MeSH terms
- Adult, Attention Deficit Disorder with Hyperactivity, Humans, Personality Disorders, Comorbidity, Prevalence, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
